MAY 23, 2018 11:44 PM PDT

Isolating The Source of Interleukin-25 In Common Respiratory Disorders

WRITTEN BY: Nouran Amin

The latest discovery from the Perelman School of Medicine at the University of Pennsylvania examined the mechanisms behind how the immune system responds to common sinus infections and asthma attacks.

 

This discovery may explain why affected individuals develop these issues in the first place with hopes to create an effective therapeutic strategy. More specifically, investigators isolated the source of the inflammatory cytokine Interleukin-25 (IL-25), which is an immune molecule that recruits a subset of inflammatory cells. Most commonly diagnosed respiratory disorders, such as chronic rhinosinusitis and asthma, have been tied to elevated levels of IL-25, but the origins remain unknown.

 

Now, the source of IL-25 is believed to be a solitary chemosensory cell (SCC). In tissue samples that are non-inflamed, SCCs compose one percent of human cells lining the sinuses. But, when the researchers examined human nasal polyps, the number of SCCs that lining the polyp tissue have strikingly increased. Furthermore, when these cells were treated with inflammatory molecule Interleukin-13 (IL-13), which has also been involved in driving nasal polyp formation and asthma, it stimulated the expansion of the SCCs and increased the production of IL-25. "The more of these cells are present, the more likely the body will mount an inappropriate, exaggerated immune response due to elevated levels of IL-25. The body ends up in a vicious cycle, and so it never goes back to its baseline," explains the study's senior author Noam A. Cohen, MD, Ph.D., director of Rhinology Research at Penn.

 

Structure of Interleukin-13

The researchers also discovered that IL-25 is not relapsed in tissues, but relapsed in the mucus. This means that IL-25 has to come from the mucus before it reaches the tissue to exert its effects. Otherwise, IL-25 remaining in the mucus site will be excreted out of the body through sneezing. "We can measure levels of IL-25 in the mucus, so it's possible this can be an indicator of who will develop conditions like polyps or asthma," adds the study's lead author Michael Kohanski, MD, Ph.D. "Also, if we can bind up IL-25 before it reaches the tissue, we may be able to prevent the inflammation altogether." SCC's secreting IL-25 is fairly a normal process, and therefore it is not something that can be prevented. "Rather, we want to control the excessive concentrations found in polyps in a targeted way, perhaps with a nasal spray," explains Cohen.

https://b98584f181.site.internapcdn.net/tmpl/v5/img/1x1.gif

Source: Journal of Allergy and Clinical Immunology

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 13, 2020
Drug Discovery & Development
APR 13, 2020
Are COVID-19 Antibody Tests a Back-to-Work Pass?
Although treatments and vaccines against COVID-19 may still be months away, antibody tests are becoming more widespread. ...
APR 21, 2020
Drug Discovery & Development
APR 21, 2020
Researchers Develop COVID-19 Nasal Spray Vaccine
Researchers from the University of Waterloo in Canada are working on a DNA-based vaccine for COVID-19 that can be applie ...
APR 10, 2020
Drug Discovery & Development
APR 10, 2020
Cancer Therapy Drug Reverses Kidney Damage
According to a study published in the journal Science Translational Medicine, a therapeutic previously used for cancer t ...
APR 20, 2020
Drug Discovery & Development
APR 20, 2020
First Successful Vaccine for Middle-East Respiratory Syndrome
Researchers have successfully completed the first-in-human clinical trial for a vaccine against MERS (Middle East Respir ...
MAY 12, 2020
Immunology
MAY 12, 2020
Disabling Genes in Immune Cells Prevents Obesity
Obesity is a $1.7 trillion problem in the United States — a value almost 10% of the nation’s gross domestic ...
MAY 19, 2020
Immunology
MAY 19, 2020
The Mystery of the Life-Saving Vaccine Solved
In the early 1900s, French bacteriologists Albert Calmette and Camille Guerin spent the better half of a decade developi ...
Loading Comments...